Mandate

Vinge advises XVIVO in connection with a directed share issue of MSEK 250

November 01, 2021 Capital Markets and Public M&A

Vinge has advised XVIVO Perfusion AB in connection with a directed new issue of shares to Swedish and international investors that contributed MSEK 250 to XVIVO.

The subscription price of SEK 335, which corresponded to the closing price on Nasdaq Stockholm, was determined through an accelerated book-building procedure arranged by Carnegie and Bryan, Garnier & Co. The proceeds will be used for the financing of XVIVO’s acquisition of Star Teams Inc. which was published on the same day as the directed share issue.

Vinge’s team primarily consisted of Anders StridEdin Agic and Anna Ståhlklo.

 

Related

Vinge is advising Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of shares whereby Xspray receives issue proceeds of approximately SEK 135 million before deduction of transaction costs.
December 03, 2024

Vinge has represented Eleda in connection with the acquisitions of Marbit Aktiebolag, FlexiRail AB, and Hanell Entreprenad i Gävle AB

Vinge has represented the leading infrastructure group Eleda in connection with the acquisitions of Marbit Aktiebolag, FlexiRail AB, and Hanell Entreprenad i Gävle AB from Vestum. These companies are engaged in contracting activities within the construction sector. The total purchase price for the shares amounts to 747 MSEK. All key executives in the companies will become shareholders in Eleda.
December 02, 2024

Vinge has advised Fortum in connection with the divestment of its recycling and waste business

Vinge, alongside among others Castrén & Snellman, has advised Fortum in connection with the divestment of its recycling and waste business to Summa Equity through its portfolio company NG Group. The debt free purchase price is approximately EUR 800 million.
December 02, 2024